Retrospective cohort analysis of antiretroviral therapy initiation timelines and clinical outcomes in adults with HIV and TB disease in KwaZulu-Natal, South Africa
International Journal of STD & AIDS · 2026
DOI: 10.1177/09564624251369565 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of STD & AIDS, 2026. Verfasst von Claudia J Jansen van Vuuren und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa. Hauptthemen laut MEDLINE: HIV Infections, Tuberculosis, Antitubercular Agents, Anti-HIV Agents. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Gates Foundation, National Institute for Health and Care Research.
Abstract (Originalsprache)
Background
We aimed to determine antiretroviral therapy (ART) initiation timing and outcomes in people living with HIV (PLHIV) receiving tuberculosis treatment in KwaZulu-Natal, South Africa.
Methods
We performed a retrospective cohort analysis of routinely collected de-identified data from 62 clinics including PLHIV not already receiving ART aged ≥16 years, starting tuberculosis treatment between October 2016–November 2019. Multivariable Poisson regression models with robust standard errors evaluated associations between timing of ART initiation (after starting tuberculosis treatment) and successful tuberculosis treatment, and 6-month HIV viral load (VL) < 50 copies/mL.
Results
Among 5,548 PLHIV with tuberculosis, 29.8% initiated ART within 15 days (“early”), 36.2% in 16–56 days, 8.7% in 57–210 days, with 25.3% not initiating ART by 7 months. Proportions with successful tuberculosis treatment were similar comparing 16–56 and 57–210 days to early initiation, with a lower likelihood of successful tuberculosis outcome with no ART within 7 months (adjusted risk ratio [aRR] 0.81 [0.77–0.86], p < 0.001). In those with a known VL 6 months post-ART initiation ( n = 2,658), initiation within 57–210 days had a lower likelihood of viral suppression (aRR 0.90 [0.82–0.99], p < 0.03).
Conclusion
Although
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.
- eThekwini Municipality Health Unit, eThekwini Municipality, Durban, South Africa.
- Bethesda Hospital, uBombo, South Africa.
- London School of Hygiene and Tropical Medicine, London, UK.
- MRC-CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, DorisDuke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
- KRISP, University of KwaZulu-Natal, Durban, South Africa.
ORCID-Profile: Claudia J Jansen van Vuuren, Jienchi Dorward
Förderung
- Wellcome Trust
- Gates Foundation
- National Institute for Health and Care Research
Zitieren
APA
Jansen van Vuuren, C. J., van der Molen, J., Sookrajh, Y., Ngwenya, T., Khubone, T., Mkhize, S., Asare, K., Naidoo, K., Lessells, R., Lewis, L., Garrett, N., & Dorward, J. (2026). Retrospective cohort analysis of antiretroviral therapy initiation timelines and clinical outcomes in adults with HIV and TB disease in KwaZulu-Natal, South Africa. International Journal of STD & AIDS. https://doi.org/10.1177/09564624251369565
Vancouver
Jansen van Vuuren CJ, van der Molen J, Sookrajh Y, Ngwenya T, Khubone T, Mkhize S, et al. Retrospective cohort analysis of antiretroviral therapy initiation timelines and clinical outcomes in adults with HIV and TB disease in KwaZulu-Natal, South Africa. International Journal of STD & AIDS. 2026. doi:10.1177/09564624251369565
BibTeX
@article{JansenvanVuuren2026,
author = {Jansen van Vuuren, Claudia J and van der Molen, Johan and Sookrajh, Yukteshwar and Ngwenya, Thulani and Khubone, Thokozani and Mkhize, Siyabonga and Asare, Kwabena and Naidoo, Kogieleum and Lessells, Richard and Lewis, Lara and Garrett, Nigel and Dorward, Jienchi},
title = {Retrospective cohort analysis of antiretroviral therapy initiation timelines and clinical outcomes in adults with HIV and TB disease in KwaZulu-Natal, South Africa},
journal = {International Journal of STD & AIDS},
year = {2026},
doi = {10.1177/09564624251369565}
}
EUVIMED